Defining the Functional Sensitivity for the Siemens Atellica Calcitonin Assay: Insight From a Single-Center Study

Area of Science:

• Endocrinology
• Oncology
• Clinical Chemistry

Background:

• Elevated post-thyroidectomy calcitonin and carcinoembryonic antigen levels suggest medullary thyroid carcinoma (MTC) presence.
• American Thyroid Association guidelines recommend frequent calcitonin measurement or imaging for early MTC detection.
• Establishing clinical cutoff values for calcitonin assays is crucial for managing persistent or recurrent MTC.

Purpose of the Study:

• To evaluate postoperative calcitonin levels using the Siemens Atellica assay system.
• To determine optimal clinical cutoff levels for detecting MTC recurrence post-thyroidectomy.

Main Methods:

• Retrospective analysis of 56 samples from 40 patients undergoing total thyroidectomy.
• Calcitonin testing using Siemens Atellica, at least 3 months post-surgery.
• Assessment of concurrent imaging studies and carcinoembryonic antigen results.

Main Results:

• Precision analysis showed coefficients of variation of 16.49% at 2.94 pg/mL and 8.87% at 5.24 pg/mL.
• A calcitonin cutoff of 1.89 pg/mL yielded 43% sensitivity and 67% specificity for MTC recurrence.
• A calcitonin cutoff of 5.00 pg/mL yielded 0% sensitivity and 100% specificity for MTC recurrence.

Conclusions:

• A 5 pg/mL calcitonin cutoff on the Siemens Atellica platform may be suitable for evaluating MTC persistence or recurrence.
• Individual laboratories should establish their own clinical cutoff values for monitoring tumor recurrence.